Events Archives - Page 3 of 7 - Precision Pathology

bioAffinity Technologies Presents its Cancer Therapeutic Research at Joint ASCB-EMBO Meeting

bioAffinity discoveries lead to novel approach that kills cancer cells without harm to normal cells by using siRNAs to selectively target multiple cancers DECEMBER 6, 2021 (SAN ANTONIO, TX) bioAffinity Vice President of Research David Elzi, Ph.D., will discuss how bioAffinity successfully uses RNA interference to knock down expression of two genes that results in […]

Vice President of Research David Elzi, PhD, will present groundbreaking research at the American Society of Cell Biology Cell Bio Virtual, December 1 – 10, 2021

Vice President of Research David Elzi, PhD, will present groundbreaking research leading to bioAffinity’s discovery of how silencing two cell receptors results in cancer cell toxicity, while normal cells are unaffected.  His presentation at the American Society of Cell Biology Cell Bio Virtual 2021 will be available December 1-10, 2021 for conference participants.  ASCB Cell […]

Maria Zannes, President and CEO, will present and meet with investors at H.C. Wainwright & Company’s 23rd Annual Global Investment Conference

bioAffinity Technologies President and CEO Maria Zannes will present the Company’s recent advancements in commercializing CyPath® Lung, a noninvasive test to diagnose early stage lung cancer and meet with investors at H.C. Wainwright & Company’s 23rd Annual Global Investment Conference, which is being held as a virtual event from September 13-15, 2021. The daily format includes […]

bioAffinity Technologies Presents Scientific Discoveries Advancing Cancer Therapeutics and Diagnostics at Two Global Conferences

JUNE 23, 2021 (SAN ANTONIO, TX) bioAffinity Technologies, a privately held biotech company, will present the Company’s discoveries in the field of cancer diagnostics and therapeutics at the RNA Therapeutics Institute’s 2021 RNA Therapeutics Symposium June 23 – 25, 2021, and the International Conference on Porphyrins and Phthalocyanines (ICPP) June 28 – July 3, 2021. […]

Dr. David Elzi will present the poster “Selective Cancer Cell Killing by Dual siRNA Knockdown of CD320 and LRP2 Receptors” at the UMASS RNA Therapeutics Symposium

Dr. Elzi will present his poster “Selective Cancer Cell Killing by Dual siRNA Knockdown of CD320 and LRP2 Receptors” at the University of Massachusetts RNA Therapeutics Symposium:  From Concept to Clinic, June 23-25, 2021.  Dr. Elzi’s live presentation will be Wednesday June 23, from 3:30PM-4:15PM EDT.  RNA Therapeutics Conference | Symposium 2020 (umassmed.edu)